Biotechnology Assets, S.A. (BST:041)
Germany · Delayed Price · Currency is EUR 0.1800
-0.0300 (-14.29%)
At close: Dec 5, 2025
Biotechnology Assets Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 3.05 | 2.97 | 3.91 | 2.96 | 3.28 | 2.89 | Upgrade | |
Revenue Growth (YoY) | -9.48% | -24.14% | 32.14% | -9.87% | 13.50% | -10.67% | Upgrade |
Cost of Revenue | 0.29 | 0.35 | 0.45 | 0.36 | 0.25 | 0.2 | Upgrade |
Gross Profit | 2.76 | 2.62 | 3.46 | 2.59 | 3.04 | 2.7 | Upgrade |
Selling, General & Admin | 2.73 | 2.95 | 2.96 | 2.56 | 3.33 | 2.18 | Upgrade |
Other Operating Expenses | -0.29 | -0.25 | -4.68 | -0.38 | -0.3 | -0.48 | Upgrade |
Operating Expenses | 4.51 | 4.9 | 0.75 | 4.33 | 5.11 | 3.91 | Upgrade |
Operating Income | -1.75 | -2.29 | 2.71 | -1.74 | -2.07 | -1.21 | Upgrade |
Interest Expense | -0.17 | -0.18 | -0.31 | -0.35 | -0.85 | -0.33 | Upgrade |
Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade |
Currency Exchange Gain (Loss) | -0.03 | -0.05 | -0.02 | 0.03 | 0.01 | -0.01 | Upgrade |
EBT Excluding Unusual Items | -1.95 | -2.52 | 2.38 | -2.05 | -2.91 | -1.56 | Upgrade |
Asset Writedown | -0.56 | -0.56 | -0.05 | - | - | - | Upgrade |
Other Unusual Items | 0.29 | 0.02 | 0 | 0.01 | 0 | 0 | Upgrade |
Pretax Income | -2.22 | -3.06 | 2.32 | -2.04 | -2.91 | -1.55 | Upgrade |
Income Tax Expense | -0.14 | -0.14 | 0.75 | -0.1 | 0.1 | 0.15 | Upgrade |
Earnings From Continuing Operations | -2.08 | -2.92 | 1.57 | -1.94 | -3.01 | -1.7 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | - | -6.9 | Upgrade |
Net Income to Company | -2.08 | -2.92 | 1.57 | -1.94 | -3.01 | -8.61 | Upgrade |
Minority Interest in Earnings | - | - | -0 | 0 | 0 | 0 | Upgrade |
Net Income | -2.08 | -2.92 | 1.57 | -1.94 | -3.01 | -8.61 | Upgrade |
Net Income to Common | -2.08 | -2.92 | 1.57 | -1.94 | -3.01 | -8.61 | Upgrade |
Shares Outstanding (Basic) | - | 66 | 58 | 54 | 46 | 39 | Upgrade |
Shares Outstanding (Diluted) | - | 66 | 58 | 54 | 46 | 39 | Upgrade |
Shares Change (YoY) | - | 14.28% | 6.50% | 18.82% | 16.39% | 0.04% | Upgrade |
EPS (Basic) | - | -0.04 | 0.03 | -0.04 | -0.07 | -0.22 | Upgrade |
EPS (Diluted) | - | -0.04 | 0.03 | -0.04 | -0.07 | -0.22 | Upgrade |
Free Cash Flow | 0.56 | -0.09 | -0.02 | -0.14 | -1.52 | 8.8 | Upgrade |
Free Cash Flow Per Share | - | -0.00 | - | -0.00 | -0.03 | 0.23 | Upgrade |
Gross Margin | 90.45% | 88.19% | 88.47% | 87.67% | 92.49% | 93.25% | Upgrade |
Operating Margin | -57.27% | -77.17% | 69.28% | -58.71% | -63.22% | -41.96% | Upgrade |
Profit Margin | -68.10% | -98.39% | 40.27% | -65.70% | -91.80% | -297.64% | Upgrade |
Free Cash Flow Margin | 18.41% | -2.96% | -0.56% | -4.90% | -46.29% | 304.47% | Upgrade |
EBITDA | -1.41 | -1.29 | 3.72 | -0.71 | -1.04 | -0.17 | Upgrade |
EBITDA Margin | -46.20% | -43.60% | 95.23% | -24.04% | -31.79% | -5.85% | Upgrade |
D&A For EBITDA | 0.34 | 1 | 1.01 | 1.03 | 1.03 | 1.04 | Upgrade |
EBIT | -1.75 | -2.29 | 2.71 | -1.74 | -2.07 | -1.21 | Upgrade |
EBIT Margin | -57.27% | -77.17% | 69.28% | -58.71% | -63.22% | -41.96% | Upgrade |
Effective Tax Rate | - | - | 32.23% | - | - | - | Upgrade |
Advertising Expenses | - | 0.05 | 0.04 | 0.01 | 0.05 | 0.03 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.